Wednesday, 20 October 2021



LATEST NEWS Shoot of web series Bhayiya Ji smile in Chandigarh 1158 posts in Government Colleges will be filled up within 45 days : Pargat Singh Health Minister, Anil Vij launches "Swasth Haryana" App Punjab Government To Allot 5-Marla Plots To Homeless Union MoS Shobha Karandlaje concludes two day Kathua tour Former Ministers, Political representatives of Ganderbal call on Lt Governor Two day J&K visit of Piyush Goyal concludes Dr. Arun Kumar Mehta chairs meeting of UT Executive Committee for Disaster Management Works on Tawi Barrage to be completed in 10 months Director, Tourism chairs rate fixation meeting of services, products Director Agriculture Kashmir Flags off Mobile Soil Testing Van DDC Srinagar chairs DLIC meet, reviews implementation of “TEJASWANI” scheme DDC Srinagar reviews implementation, registration of unorganized workers on e-SHRAM Portal Divisional Commissioner Kashmir reviews implementation of NGT directions Advisor Farooq Khan pays obeisance at Hazratbal on Milad-un-Nabi (SAW) Panchkula-Morni road project will give further impetus to the development of Panchkula : Manohar Lal Khattar Charanjit Singh Channi Disburses Cheques Worth Rs. 27 Crore For 63 Villages In Block Morinda Modi Govt’s Move To Extend BSF Jurisdiction Will Annihilate Economic Prosperity Of Punjab : Rana Gurjeet Singh Beneficiaries Of Electricity Bills Upto 2 KW Load Can Visit PSPCL‘s Suvidha Centre For Waiving Off The Aarrears : DC Jalandhar Drug awareness campaign will be run in the state : J.C. Sharma AAP will get back every penny of victims of Pearls and other chit fund scams : Kulwant Singh Pandori


Chinese vax firms prepare facilities for mass production

Web Admin

Web Admin

5 Dariya News

Beijing , 06 Sep 2020

The Covid-19 vaccine produced by China's Sinovac Biotech has entered Phase-3 trial globally and the biopharma company displayed it during the 'China International Fair for Trade in Services' in Beijing this weekend.The Sinovac vaccine has been in Phase-3 clinical trials since July.Phase-1 and 2 trials have shown the vaccine to be safe and effective without serious side effects, reports CGTN."After performing injections on over 1,000 volunteers, some only showed minor fatigue or discomfort, no more than 5 per cent," Yin Weidong, chairman and CEO of Sinovac Biotech, was quoted as saying."Fever is a major index by which we evaluate a vaccine's safety, limited to about 2 to 3 per cent. As for effectiveness, after two injections, almost all volunteers developed antibodies, around 97 to 98 per cent."To prepare for potential mass production, the company has reportedly built a 20,000 square metre production plant."Our facility has been designed to produce 300 million doses annually," Yin said.Along with Sinovac's vaccine, China has three other Covid-19 vaccine candidates that have entered Phase-3 clinical trials.The China National Pharmaceutical Group's candidate vaccine, an inactivated type, entered Phase-3 trials in late June. The company said its facilities in Beijing and Wuhan can produce 2.2 million doses a year.If things go well, these two vaccines are expected to enter the market by the end of this year, according to the vaccine developers.


Tags: Coronavirus , COVID 19 , Novel Coronavirus , India Fights Corona , Fight Against Corona , Stay Home Stay Safe , Stay Home , Corona Virus Updates , Coronavirus Epidemic , Coronavirus Pandemic , Corona virus threat , Corona Outbreak , Covid-19 vaccine , Beijing , China , Sinovac Biotech



related news




Photo Gallery



Video Gallery



5 Dariya News RNI Code: PUNMUL/2011/49000
© 2011-2021 | 5 Dariya News | All Rights Reserved
Powered by: CDS PVT LTD